Kiniksa Pharmaceuticals is looking to create a Virtual Recurrent Pericarditis Advisory Board. We’re inviting individuals affected by recurrent pericarditis, both in the US and internationally, to participate in this important initiative.

This virtual board will provide patients the opportunity to share their unique perspectives and experiences, helping to shape future insights into the patient journey with recurrent pericarditis. The session will take place online in mid-March and last around two hours (exact date and time to be determined).

Patient advisors will be compensated for their valuable time and input. If you’re interested in participating or know someone who might be, we encourage you to reach out and get involved.

Let’s make a difference together by sharing our voices to improve care and understanding of recurrent pericarditis!

For more information or to express your interest, please contact [email protected]

Contact Us

Contact Us

(281) 713-2962
800 Rockmead Drive, Suite 155
Kingwood, TX 77339
[email protected]

Social Media

Donations

Help Us End Suffering and Sudden Death from Myocarditis!

Donate to the Myocarditis Foundation Today!